 |
|
Screening strategy for non-alcoholic fatty liver disease
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Clin Mol Hepatol. 2023;29(Suppl):S103-S122. Published online 2022 Nov 30 DOI: https://doi.org/10.3350/cmh.2022.0336
|
|
Citations to this article as recorded by
 Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
Philipp Kasper, Münevver Demir, Hans-Michael Steffen
Clinical and Molecular Hepatology.2023; 29(2): 390. CrossRef Regression of nonalcoholic fatty liver disease is associated with reduced risk of incident diabetes: A longitudinal cohort study
Dong Hyun Sinn, Danbee Kang, Eliseo Guallar, Sung Chul Choi, Yun Soo Hong, Yewan Park, Juhee Cho, Geum-Youn Gwak, Ahmed Mustafa Rashid
PLOS ONE.2023; 18(7): e0288820. CrossRef Non-alcoholic fatty liver disease – a challenging health problem of the 21st century
Anamaria Cozma-Petruţ, Lorena Filip , Doina Miere
Dietetician.ro.2023; 2(2): 30. CrossRef
|